Mark S Schroeder
CIK 1793112 · EVP, Pres Diagnostics & COO · last filed 2026-03-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.20M
Companies
1
Total Filings
43
Lifetime Open-Market Net
-$7.42M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LH | EVP, Pres Diagnostics & COO | 15,777 | $266.16 | $4.20M | -$7.42M | 43 | 2026-03-30 |
Recent Filings · Page 2 of 5
43 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-13 | LH | Mixed | +346 | -$28.7K | EDGAR |
| 2024-02-08 | LH | Mixed | +498 | -$40.7K | EDGAR |
| 2024-02-06 | LH | Mixed | +363 | -$29.2K | EDGAR |
| 2023-07-05 | LH | Grant (A) | — | $0 | EDGAR |
| 2023-05-22 | LH | Mixed | — | -$129.3K | EDGAR |
| 2023-05-09 | LH | Grant (A) | — | $0 | EDGAR |
| 2023-04-03 | LH | Mixed | — | -$1.52M | EDGAR |
| 2023-02-16 | LH | Sell (S) | −309 | -$76.5K | EDGAR |
| 2023-02-14 | LH | Mixed | +309 | -$28.3K | EDGAR |
| 2023-02-09 | LH | Mixed | −409 | -$99.4K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.